1Chevaliez S,Bouvier-Alias M,Laperche S,et al.Performance of version 2.0 of the Cobas AmpliPrep/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification[J].J Clin Microbiol,2010,48(10):3641-3647.
2Ciotti M,Marcuccilli F,Guenci T,et al.Evaluation of the Abbott RealTime HBV DNA assay and comparison to the Cobas AmpliPrep/Cobas TaqMan 48 assay in monitoring patients with chronic cases of hepatitis B[J].J Clin Microbiol,2008,46(4):1517-1519.
5Mason AL,Xu L,Guo L,et al.Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitisB surface antigen[J].Hepatology,1998,27(6):1736-1742.
6Bowden DS,Thompson AJ.New developments in HBV molecular diagnostics and quantitative serology[J].Hepatol Int,2008,2(Suppl 1):3-11.
7Caliendo AM,Valsamakis A,Bremer JW,et al.Multilaboratory evaluation of real-time PCR tests for hepatitis B virus DNA quantification[J].J Clin Microbiol,2011,49 (8):2854-2858.
8European Association For The Study Of The Liver.EASL clinical practice guidelines:Management of chronic hepatitis B virus infection[J].J Hepatol,2012,57(1):167-185.
10Saldanha J,Gerlich W,Lelie N,et al.An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques[J].Vox Sang,2001,80 (1):63-71.
2European Association For the Study of the Liver. EASL clinical prac- tice guidelines: Management of chronic hepatitis B virus infection [ J]. J Hepatol,2012,57 ( 1 ) : 167-185.
4Clinical and laboratory standards institute. User verification of per- formance for precision and trueness: approved guideline-second edi- tion[ S]. EP15-A2, CLSI,2005.
5NCCLS. Evaluation of the linearity of quantitative measurement proce- dures: A statistical approach. Approved guideline NCCLS document EP6-A[SI. Wayne, Pa: NCCLS, 2003.
6药监总局通告[2013]3号.乙型肝炎病毒脱氧核糖核酸定量检测试剂注册技术审查指导原则.
7Kwak MS, Kim YJ. Occult hepatitis B virus infection [ J ]. World J Hepatol,2014,6(12) : 860-869.
8Yu MW, Hsu FC, Sheen IS, et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers [J]. Am J Epidemiol, 1997, 145 (11 ) : 1039-1047.
9Iloeje UH, Yang HI, Chen CJ. Natural history of chronic hepatitis B : what exactly has REVEAL revealed? [J]. Liver Int, 2012, 32 (9) : 1333-1341.
10Nien HC, Shell JC, Kao JH, et al. Aboriginal Taiwan Residents hepatitis B carriers have more favorable viral factors than Han Chinesecarriers[J]. J Med Virol,2011,83(8) : 1326-1331.
